NCM · Medical - Instruments & Supplies

FEMY (FEMY) Stock

$3.06 -17.52% NCM: FEMY Healthcare

Valuation

MetricValue
Price$3.06
Market Cap$9.24M
P/E Ratio-0.74
P/B Ratio1.72
P/S Ratio4.35
EPS (TTM)$-0.47
52-Week High$22.20
52-Week Low$3.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-316.67%
ROA-90.48%
ROCE-300.00%
Gross Margin-900.00%
Operating Margin-900.00%
Net Margin-5.22%
Debt/Equity0.65
Current Ratio4.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$2.0M$2.0M
Operating Profit$-8.0M$-12.0M$-15.0M$-18.0M$-18.0M
Net Profit$-8.0M$-11.0M$-14.0M$-19.0M$-19.0M
EPS$-0.64$-0.97$-0.93$-0.84$-0.47
Op Margin-706.7%-961.7%-1353.4%-1091.8%-767.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$29.0M$17.0M$28.0M$12.0M$21.0M
Total Liabilities$2.0M$2.0M$9.0M$10.0M$15.0M
Cash$25.0M$13.0M$22.0M$3.0M$9.0M
Borrowings$1.0M$1.0M$7.0M$7.0M$5.0M

Latest News

Femasys Regains Compliance With Nasdaq Minimum Bid Price Rule MT Newswires · Jun 24, 2026 Femasys Regains Compliance with Nasdaq Listing Requirements GlobeNewswire · Jun 24, 2026 Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More Motley Fool · May 29, 2026 Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter GlobeNewswire · May 13, 2026 Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update GlobeNewswire · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-8.0M$-11.0M$-11.0M$-19.0M$-19.0M
Investing Cash Flow$-1.0M$-1.0M$0$-2.0M$-1.0M
Financing Cash Flow$-2.0M$0$2.0M$0$-2.0M
Net Cash Flow$21.0M$-12.0M$9.0M$-18.0M$6.0M
Free Cash Flow$-8.0M$-11.0M$-11.0M$-20.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-179.61%
Quick Ratio1.98
Interest Coverage-9.00
Return 1Y-80.87%
Return 3Y-56.57%
Return 5Y-97.62%

Ownership

Insiders Held9.40%
Institutions Held10.11%
Institutions Float Held11.16%
Institutional HolderSharesReport Date
Dauntless Investment Group, LLC 301,6522026-03-31
Vanguard Capital Management LLC61,8342026-03-31
Geode Capital Management, LLC31,0692026-03-31
Vanguard Fiduciary Trust Co12,4942026-03-31
Blackrock Inc.8,9252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About FEMY

FEMY is led by CEO Kathy Lee-Sepsick, employs 69 people, headquartered in US, publicly traded since 2021.

FEMY stock trades at $3.06 with a market capitalization of $9.24M. The stock is valued at a price-to-earnings (P/E) ratio of -0.74, price-to-book of 1.72, price-to-sales of 4.35. Over the past 52 weeks the stock has ranged between $3.06 and $22.20, and currently trades 86.2% below its 52-week high.

On profitability, FEMY generates a return on equity (ROE) of -316.67%, return on capital employed of -300.00%, an operating margin of -900.00%, a net profit margin of -5.22%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides